Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
Patent
1986-12-29
1990-05-15
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
3,10-dihydroxy-2-naphthacene carboxamide or derivative doai
A61K 3165
Patent
active
049258338
ABSTRACT:
Tetracyclines, antibacterial and non-antibacterial tetracyclines, have been found to be useful in the treatment of osteoporosis in humans by administering to the human suffering from osteoporosis an effective amount of a tetracycline to enhance bone protein synthesis. Tetracyclines which have been found to be effective in the treatment of osteoporosis in humans include minocycline, doxycycline and dedimethylaminotetracyline.
REFERENCES:
patent: 2895880 (1959-07-01), Rosenthal
patent: 3304227 (1967-02-01), Loveless
patent: 4371465 (1983-01-01), McGregor
Chemical Abstracts, 100:96203a (1983).
Golub Lorne M.
McNamara Thomas F.
Ramamurthy Nungavaram S.
Schenkman Leonard
The Research Foundation of State University of New York
LandOfFree
Use of tetracycline to enhance bone protein synthesis and/or tre does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of tetracycline to enhance bone protein synthesis and/or tre, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tetracycline to enhance bone protein synthesis and/or tre will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-621624